ABIOMED Inc. (NASDAQ: ABMD) stock closed at 348.96 per share at the end of the most recent trading day (a 1.15% change compared to the prior day closing price) with a volume of 174.76K shares and market capitalization of 15.93B. Is a component of S&P 500, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 1536 people. ABIOMED Inc. CEO is Michael R. Minogue.

The one-year performance of ABIOMED Inc. stock is 35.14%, while year-to-date (YTD) performance is 7.64%. ABMD stock has a five-year performance of 182.49%. Its 52-week range is between 242.73 and 387.4, which gives ABMD stock a 52-week price range ratio of 74.80%

ABIOMED Inc. currently has a PE ratio of 105.30, a price-to-book (PB) ratio of 12.32, a price-to-sale (PS) ratio of 16.86, a price to cashflow ratio of 54.30, a PEG ratio of 2.32, a ROA of 11.12%, a ROC of 12.82% and a ROE of 12.50%. The company’s profit margin is 16.78%, its EBITDA margin is 30.70%, and its revenue ttm is $935.26 Million , which makes it $20.61 revenue per share.

Of the last four earnings reports from ABIOMED Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.98 for the next earnings report. ABIOMED Inc.’s next earnings report date is 04th Nov 2021.

The consensus rating of Wall Street analysts for ABIOMED Inc. is Moderate Buy (2.19), with a target price of $387.33, which is +10.37% compared to the current price. The earnings rating for ABIOMED Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ABIOMED Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ABIOMED Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 14.95, ATR14 : 8.97, CCI20 : -127.61, Chaikin Money Flow : 0.03, MACD : 1.98, Money Flow Index : 27.19, ROC : -6.37, RSI : 47.29, STOCH (14,3) : 18.54, STOCH RSI : 0.34, UO : 50.40, Williams %R : -81.46), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ABIOMED Inc. in the last 12-months were: Andrew J. Greenfield (Option Excercise at a value of $662 500), Andrew J. Greenfield (Sold 34 312 shares of value $11 104 551 ), David M. Weber (Option Excercise at a value of $300 950), David M. Weber (Sold 13 000 shares of value $4 019 635 ), Dorothy E. Puhy (Sold 5 000 shares of value $1 747 347 ), Martin P. Sutter (Sold 24 900 shares of value $7 501 672 ), Michael R. Minogue (Option Excercise at a value of $1 967 750), Michael R. Minogue (Sold 85 000 shares of value $28 913 282 ), Paul G. Thomas (Sold 663 shares of value $219 301 )